Mark H. Schutta, MD

Diabetes
Accepting new patients
Sees patients age 18 and up
Penn Rodebaugh Diabetes Center
Schedule onlineCall 215-662-2468
Penn Medicine Provider

About me

  • Medical Director, Penn Rodebaugh Diabetes Center
  • G. Clayton Kyle Professor in Diabetes

My education and training

  • Medical School: Thomas Jefferson University
  • Residency: Thomas Jefferson University Hospital
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Reviews

Average Rating

810 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
May 2026
because i like him and he does a great job
Anonymous
April 2026
overall good experience
Anonymous
April 2026
dr schutta's knowledge, talent, keeping up with recent medical developments, time he spent on reviewing results of my blood test, looking at history and how changes in prescription drugs he made worked, etc
Anonymous
April 2026
everything was great

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Schutta is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Martin SS., Qasim AN., Mehta NN., Wolfe M., Terembula K., Schwartz S., Iqbal N., Schutta M., Bagheri R., Reilly MP. Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites , Diabetes, 58: 2009,1887-1892

Schutta MH. Diabetes and Hypertension , Journal of Cardiometabolic Syndrome: 2007,124-130

Rickels MR., Schutta MH., Mueller R., Kapoor S., Markmann JF., Naji A., Teff KL. Glycemic Thresholds for Activation of Counterregulatory Hormone and Symptom Responses in Islet Transplant Recipients , J Clin Endocrinol Metab, 92(3): 2007,873-9

Cardillo S., Schutta MH. Repaglinide Induced Hypoglycemia in a Patient with Cystic Fibrosis-Related Diabetes Mellitus , Endo Trends, 13(4): 2006,6-7

Rickels MR., Schutta MH., Markmann JF., Barker CF., Naji A., Teff KL. Beta-cell function following human islet transplantation for type 1 diabetes , Diabetes, 54(1): 2005,100-6

Rickels MR., Schutta MH., Markmann JF., Barker CF., Naji A., Teff KL. Beta-Cell Function Following Human Islet Transplantation for Type 1 Diabetes Mellitus: Preliminary Results , Oral presentation at the American Diabetes Association Meeting: 2007

Reilly MP., Iqbal N., Schutta M., Wolfe ML., Scally M., Localio AR., Rader DJ., Kimmel SE. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes , J Clin Endocrinol Metab, 89(8): 2004,3872-8